Abstract: In general, techniques are described for providing an isolation virtual local area network (VLAN) for layer two access networks. A server comprising an interface and a control unit may implement the techniques. The interface receives a message that initiates a request for a layer three (L3) network address for use by a client device via an isolation virtual local area network (VLAN) that supports transmitting data from a network device to the server, where the network device is intermediately positioned between the client device and the server. The message includes a layer two (L2) address associated with the client device. The control unit determines whether to allow the client device to access the network and assigns the L3 network address to the client device based on the determination.

Abstract: In general, this disclosure describes network security techniques that may accommodate legitimate movement of a subscriber device while preventing MAC collisions that may result from configuration errors or MAC spoofing attempts. MAC spoofing may result in packets directed to one subscriber device being sent instead to another subscriber device. By modifying an access node or a Dynamic Host Configuration Protocol (DHCP) server to allow only authorized subscriber devices on the access network, layer two collisions (“MAC collisions”) may be prevented.

Abstract: In general, this disclosure describes network security techniques that may accommodate legitimate movement of a subscriber device while preventing MAC collisions that may result from configuration errors or MAC spoofing attempts. MAC spoofing may result in packets directed to one subscriber device being sent instead to another subscriber device. By modifying an access node or a Dynamic Host Configuration Protocol (DHCP) server to allow only authorized subscriber devices on the access network, layer two collisions (“MAC collisions”) may be prevented.

Abstract: In general, techniques are described for providing an isolation virtual local area network (VLAN) for layer two access networks. A server comprising an interface and a control unit may implement the techniques. The interface receives a message that initiates a request for a layer three (L3) network address for use by a client device via an isolation virtual local area network (VLAN) that supports transmitting data from a network device to the server, where the network device is intermediately positioned between the client device and the server. The message includes a layer two (L2) address associated with the client device. The control unit determines whether to allow the client device to access the network and assigns the L3 network address to the client device based on the determination.

Abstract: Disclosed are pharmaceutical compositions containing a cyclodextrin and a therapeutically effective amount of a glycopeptide antibiotic or a salt thereof. Also disclosed are methods of treating a bacterial disease in a mammal by administering such pharmaceutical compositions.

Abstract: In general, this disclosure describes network security techniques that may accommodate legitimate movement of a subscriber device while preventing MAC collisions that may result from configuration errors or MAC spoofing attempts. MAC spoofing may result in packets directed to one subscriber device being sent instead to another subscriber device. By modifying an access node or a Dynamic Host Configuration Protocol (DHCP) server to allow only authorized subscriber devices on the access network, layer two collisions (“MAC collisions”) may be prevented.

Abstract: In general, this disclosure describes network security techniques that may accommodate legitimate movement of a subscriber device while preventing MAC collisions that may result from configuration errors or MAC spoofing attempts. MAC spoofing may result in packets directed to one subscriber device being sent instead to another subscriber device. By modifying an access node or a Dynamic Host Configuration Protocol (DHCP) server to allow only authorized subscriber devices on the access network, layer two collisions (“MAC collisions”) may be prevented.

Abstract: Disclosed are pharmaceutical compositions containing a cyclodextrin and a therapeutically effective amount of a glycopeptide antibiotic or a salt thereof. Also disclosed are methods of treating a bacterial disease in a mammal by administering such pharmaceutical compositions.

Abstract: Disclosed are pharmaceutical compositions containing a cyclodextrin and a therapeutically effective amount of a glycopeptide antibiotic or a salt thereof. Also disclosed are methods of treating a bacterial disease in a mammal by administering such pharmaceutical compositions.

Abstract: Disclosed are pharmaceutical composition containing a cyclodextrin and a therapeutically effective amount of a glycopeptide antibiotic or a salt thereof. Also disclosed are methods of treating a bacterial disease in a mammal by administering said pharmaceutical composition.

Abstract: Disclosed are pharmaceutical compositions containing a cyclodextrin and a therapeutically effective amount of a glycopeptide antibiotic or a salt thereof. Also disclosed are methods of treating a bacterial disease in a mammal by administering such pharmaceutical compositions.

Abstract: Disclosed are pharmaceutical compositions containing a cyclodextrin and a therapeutically effective amount of a glycopeptide antibiotic or a salt thereof. Also disclosed are methods of treating a bacterial disease in a mammal by administering such pharmaceutical compositions.

Abstract: Disclosed are pharmaceutical compositions containing a cyclodextrin and a therapeutically effective amount of a glycopeptide antibiotic or a salt thereof. Also disclosed are methods of treating a bacterial disease in a mammal by administering such pharmaceutical compositions.